A Study of Role of Immunohistochemical Markers in Management of Carcinoma Breast
International Journal of Pharmaceutical Quality Assurance · 30.06.2026 · 17 (06)
DOI: 10.25258/ijpqa.17.6.28 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.06.2026. Verfasst von Karlapudy Chandra Mohan Prakash und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Breast carcinoma remains the most commonly diagnosed malignancy among women worldwide and a leading cause of cancer-related mortality. Immunohistochemical (IHC) markers such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) provide crucial prognostic and predictive information, enabling personalized treatment strategies. Differences in receptor expression according to menopausal status may influence disease behaviour and therapeutic outcomes. Aim and Objectives: To evaluate the expression of ER, PR, and HER2/neu in breast carcinoma and assess their association with menopausal status. The study also aimed to compare receptor expression patterns between premenopausal and postmenopausal women and determine their utility in guiding prognosis and treatment. Methodology: This prospective observational study was conducted over 22 months in the Department of General Surgery, Government General Hospital, Guntur. Sixty women with histologically confirmed breast carcinoma were enrolled and categorized into premenopausal (n=30) and postmenopausal (n=30) groups. Clinical, demographic, pathological, and reproductive data were collected using a structured proforma. Immunohistochemical analysis for ER, PR, and HER2/neu expression was performed using standardized protocols, and comparative statistical analysis was undertaken.
Results
The mean age was significantly lower in premenopausal women (42.8±3.4 years) than postmenopausal women (62.1±7.6 years; p
Zitieren
APA
Prakash, K. C. M., Melchizedek, K. M., Gandham, S. R., & Manoja, C. (2026). A Study of Role of Immunohistochemical Markers in Management of Carcinoma Breast. International Journal of Pharmaceutical Quality Assurance, 17(06). https://doi.org/10.25258/ijpqa.17.6.28
Vancouver
Prakash KCM, Melchizedek KM, Gandham SR, Manoja C. A Study of Role of Immunohistochemical Markers in Management of Carcinoma Breast. International Journal of Pharmaceutical Quality Assurance. 2026;17(06). doi:10.25258/ijpqa.17.6.28
BibTeX
@article{Prakash2026,
author = {Prakash, Karlapudy Chandra Mohan and Melchizedek, K. Manohar and Gandham, Sri Ram and Manoja, C.},
title = {A Study of Role of Immunohistochemical Markers in Management of Carcinoma Breast},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {06},
doi = {10.25258/ijpqa.17.6.28}
}
EUVIMED